The nation of Zimbabwe has rejected a substantial American healthcare agreement valued at 367 million US dollars (£272m) spanning five years because of Washington's demand for confidential data.
This rejection came to light after a internal memorandum dated December was leaked, indicating that President Emmerson Mnangagwa deemed the arrangement was "unbalanced".
A government spokesperson later explained that the US was requesting biological samples for research and profit but was unwilling to share the resulting advantages from any future vaccines.
"We will now turn to the challenging and unfortunate task of scaling back our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had donated over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for continued dialogue to reach a deal agreeable to both sides so the country's vital HIV programme can proceed.
Broader Background
This development follows a similar case in Kenya, where a high court suspended a similar deal with the US following concerns were filed about the security of citizens' medical information.
Since returning to office recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
USAID had managed aid for the US government, but Trump claimed its expenditure was "wasteful" and his government was seeking direct bilateral deals to enhance transparency and responsibility.
Based on reports, 16 nations in Africa have to date signed similar agreements, constituting more than $18.3bn of fresh investment.
Specifics of the Declined Agreement
This assistance for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this collaboration might have yielded significant benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving HIV treatment through American-funded initiatives," Tremont commented.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"Zimbabwe was being asked to share its genetic material and health information for a long time, without any equivalent assurance of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.
"In essence, our country would provide the raw materials for scientific discovery without any assurance that the end products would be accessible to our people should a future pandemic emerge."
Sovereignty and Global Health
He also said that the American exit from the global health body and its pursuit of one-on-one health agreements were upending systems already set up via the international organization.
The spokesperson cited its Pandemic Benefit-Sharing framework designed to manage potential pandemics.
"This mechanism is designed to ensure that when a nation contributes its data, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised solely by those with the capability to create them."
These objections regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We welcome continued discussions with our US partners on how subsequent co-operation could be designed in a manner that respects the sovereignty and interests of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the government's concerns, but suggested that talks must proceed since much of the nation's Aids initiatives relied on international support.
"In cases where specific concerns exist, such as those involving information security or implementation frameworks, these can frequently be resolved through technical clarification and negotiated safeguards," the group added.
The situation underscores the complex challenges between accepting vital foreign assistance and safeguarding a country's data in an increasingly data-driven world.